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Prescribing is at the core of the therapeutic effortsmade by doctors both in hospital and in primary care.Observational studies have highlighted the challenges
to delivering high-quality clinical outcomes for patients in
both settings. Avoidable adverse effects of medicines are a
common cause of admission to hospital1 and occur fre-
quently in those who are admitted.2 Medication errors are
also common. A recent prospective observational study in
the United Kingdom showed that 10% of prescriptions in
hospital contained errors and that senior doctors were culpa-
ble almost as frequently as recent graduates.3 Patients are
often denied some of the most evidence-based treatments
while being maintained on those that are unnecessary.4,5
Finally, rates of adherence to long-term therapy are often
low,6 which calls into question the confidence that patients
have in their physicians and the medicines they prescribe.
For prescribing to be of high quality, it should be safe,
effective, cost-effective and patient-centred.7 Perhaps we
should not be surprised that it often falls short of this ideal.
Prescribing is a complex task that requires diagnostic skills,
knowledge of medicines, communication skills, an under-
standing of the principles of clinical pharmacology, apprecia-
tion of risk and uncertainty and, ideally, experience. The
demands placed on prescribers are also rising because of the
increased choice of medicines available, expanding indications
for drug treatment, greater complexity of treatment regimens
and associated polypharmacy, and a growing elderly patient
population. The other major challenge is the pace of change in
therapeutics. New evidence on effectiveness, emerging safety
signals and changing costs means that what is considered good
prescribing today may not necessarily be so in a year.
The sheer volume of prescriptions means that some poor
outcomes are inevitable. However, every effort should be
made to improve quality and minimize risk. Two research
articles published recently in CMAJ illustrate the difficulties
in achieving such improvements. In the first, Shojania and
colleagues report their findings from a systematic review of
randomized studies evaluating improvements in processes of
care from computer reminders delivered to clinicians during
routine electronic ordering or charting activities.8 Across the
28 trials (reporting 32 comparisons), the authors found that
computer reminders improved adherence to processes of care
(appropriate prescribing or ordering of tests) by a median of
only 4.2%. Systems that required users to enter a response
provided larger improvements (median 12.9%). The largest
effect (median 16.8%) was seen in one institution with a well-
developed, “homegrown” clinical information system.
Although there is little information about the baseline perfor-
mance or clinical outcomes, these modest gains should make
us reconsider the extent of our expectations for computer
reminder systems.
In the second article, Villeneuve and colleagues report on
their investigation into the efficacy of a collaborative model
involving family physicians and community pharmacists in
improving the care of patients with dyslipidemia.9 The phar-
macists counselled patients about their medications and
lifestyle changes, requested laboratory tests, monitored the
effectiveness and safety of medications and patients’ adher-
ence to treatment, and adjust ed medication dosages. Com-
pared with patients assigned to receive usual care (presum-
ably reflecting a more cautious or cost-effective approach of
the pharmacists), patients in the collaborative care group
were much less likely to receive high-potency statins, had
more visits with health care professionals and more labora-
tory tests, and were more likely to have their lipid- lowering
treatment changed and to report lifestyle changes. After a
year of follow-up, the mean reduction in low-density lipo -
protein (LDL) cholesterol in the collaborative care group was
small and only slightly better than the reduction in the usual
care group (crude difference −0.2 mmol/L; adjusted differ-
ence −0.05 mmol/L).
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Key points
• Prescribing often falls short of the ideal of being safe,
effective, cost-effective and patient-centred.
• Improving prescribing practices and clinical outcomes is an
important challenge for all health care providers.
• Interventions targeted at individual prescribers and the
systems in which they work can help to improve
prescribing.
• Important approaches include undergraduate and
postgraduate education, local formularies, incentive
schemes, review and feedback on prescribing, and
computerized physician order entry with decision support.
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Taken together, these articles imply that achieving mean-
ingful improvements in prescribing behaviour is difficult.
However, any pessimism should be mitigated by the apparent
success of the pharmaceutical industry. With a careful and
well-funded combination of attractive literature, development
of personal relationships, product placement, and educational
events often involving subtle support for new products by key
opinion leaders, the pharmaceutical industry very effectively
manages to change prescribing habits. As Moynihan put it,
“Food, flattery and friendship are all powerful tools of persua-
sion, particularly when combined.”10 But the industry is also
methodical in its approach: drug representatives get to know
their physicians, analyze what they do and use this as the
basis for seeking change.11
Could publicly funded health care systems be as effective
as the pharmaceutical industry? Although they cannot flex the
same financial muscle, they do have power, as employers and
regulators, to exert their own influence on individual pre-
scribers and the environments in which they work.
Prescribers could be better equipped to confront the pres-
sures they face. First, and foremost, all doctors need to start
their careers with a firm understanding of clinical pharmacol-
ogy, the science that underpins rational use of medicines. This
will enable them to critically evaluate the many sources of
information they get and respond to change. Medical schools
should respond to the widespread concerns about adverse
medication events by making competence in prescribing a
prominent feature of their curricula and assessments. This
education process should continue into the postgraduate
years, with protected time to attend professional development
programs led by the service rather than by the pharmaceutical
industry. Prescribers are influenced by meaningful feedback
on quality markers, such as antibiotic use,12 and should be
given information that allows them to reflect on and change
their current prescribing practices. Clinical units should audit
adverse medication events at regular intervals.
Health care systems could do more to improve matters.
The development of formularies can change prescribing prac-
tice, especially if they are locally owned and supported.13
Incentive schemes are also an effective means of promoting
the use of evidence-based and cost-effective prescribing.14
The checking and review of prescriptions by prescribing col-
leagues and other professionals such as nurses and pharma-
cists could be embedded into routine practice. Pharmacists
not only prevent errors reaching patients3 but can also support
the prescribing process by educating patients and improving
clinical outcomes.9,15 Notwithstanding the reservations that
arise from the study by Shojania and colleagues,8 computer
reminder systems, and their associated decision support tools,
will play an increasingly important role in minimizing error
and helping physicians to make good prescribing choices.
However, despite their increasing sophistication, these re -
minder systems do not prescribe, they simply provide further
information on which decisions can be based. Prescribers will
still be called upon to make judgments about warnings and
other information alerts that will, ultimately, be influenced by
their individual training and instincts.
Competing interests: None declared.
REFERENCES
1. Leendertse AJ, Egberts ACG, Stoker LJ, et al.; HARM Study Group. Frequency of
and risk factors for preventable medication-related hospital admissions in the
Netherlands. Arch Intern Med 2008;168:1890-6.
2. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-
patients: a prospective analysis of 3695 patient-episodes. PLoS One 2009;4:e4439.
doi:10.1371/journal.pone.0004439.
3. Dornan T, Ashcroft D, Heathfield H, et al. An in depth investigation into causes
of prescribing errors by foundation trainees in relation to their medical educa-
tion — EQUIP study. London (UK): General Medical Council; 2009. Available:
www.gmc -uk .org /FINAL _Report _prevalence _and _causes _of _prescribing _errors
.pdf _28935150.pdf (accessed 2010 Mar. 4).
4. Kanji S, Corman C, Douen AG. Blood pressure management in acute stroke: com-
parison of current guidelines with prescribing patterns. Can J Neurol Sci 2002; 29:
125-31.
5. Aronson JK. Prescribing statins. Br J Clin Pharmacol 2005;60:457-8.
6. Caro JJ, Speckman JL, Salas M, et al. Effect of initial drug choice on persistence
with antihypertensive therapy: the importance of actual practice data. CMAJ 1999;
160:41-6.
7. British Pharmacological Society. Ten principles of good prescribing. London (UK):
The Society; 2010. Available:  www.bps.ac.uk /guidelines /BPSPrescribingPrinciples
.pdf (accessed 2010 Mar. 4).
8. Shojania KG, Jennings A, Mayhew A, et al. Effect of point-of-care computer
reminders on physician behaviour: a systematic review. CMAJ 2010;182:458-64.
9. Villeneuve J, Genest J, Blais L, et al. A cluster randomized controlled Trial to
Evaluate an Ambulatory primary care Management program for patients with dys-
lipidemia: the TEAM study. CMAJ 2010;182:447-55.
10. Moynihan R. Who pays for the pizza? Redefining the relationships between doc-
tors and drug companies. 1: Entanglement. BMJ 2003;326:1189-92.
11. Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and
influence doctors. PLoS Medicine 2007;4:621-5.
12. Zwar N, Henderson J, Britt H, et al. Influencing antibiotic prescribing by pre-
scriber feedback and management guidelines: a 5-year follow-up. Fam Pract 2002;
19: 12-7.
13. Gunnarsdóttir AI, Kinnear M. Factors that influence prescribers in their selection
and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs. Pharm
World Sci 2005;27:316-20.
14. Bateman DN, Campbell M, Donaldson L, et al. A prescribing incentive scheme for
non-fundholding general practices: an observational study. BMJ 1996;313:535-8.
15. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to
improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
Correspondence to: Prof. Simon Maxwell, Clinical Pharmacology
Unit, University of Edinburgh, Clinical Research Centre, Western
General Hospital, Edinburgh  EH4 2XU, UK; s.maxwell@ed.ac.uk
